ArticleEuropean journal of hospital pharmacy : science and practice2017

Biosimilar infliximab for the management of rheumatoid arthritis in France: what are the expected savings?

M Beck et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.